News & Events

Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers …

Read more

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

Researchers at the University of Miami Miller School of Medicine have validated a biomarker for amyotrophic lateral sclerosis (ALS) – a finding that could lead to faster and more efficient …

Read more

ALS Center investigators host first international Pre-Symptomatic ALS Workshop

The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in …

Read more

CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since …

Read more

Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment

An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller …

Read more